Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 49,190Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Helvepharm AG

02 2ASTRAZENECA UK LTD

03 1Accord Healthcare AG

04 1AstraZeneca AG

05 2AstraZeneca UK Limited

06 1AstraZeneca UK Ltd.,

07 1Curatis AG

08 1Sandoz A / S,

09 1Sandoz Pharmaceuticals AG

10 1Teva Pharma AG

11 1Xiromed SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Fulvestrantum

Brand Name : Fulvestrant Zentiva

Dosage Form : Inj Solution

Dosage Strength : 250mg/5ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrantum

Brand Name : Fulvestrant Accord

Dosage Form : Inj Solution

Dosage Strength : 250mg/5ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

fulvestrant

Brand Name : Faslodex

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 250 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrant

Brand Name : Faslodex

Dosage Form : Fulvestrant 250Mg 5Ml 1 Units Parenteral Use

Dosage Strength : 1 syringe IM 5 ml + 1 needle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrant

Brand Name : Faslodex

Dosage Form : Fulvestrant 250Mg 5Ml 2 Units Parenteral Use

Dosage Strength : IM 2 Syringes 5 ml + 2 needles

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrant

Brand Name : Faslodex

Dosage Form : Injection fluid, resolution

Dosage Strength : 250 mg/5 ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrant

Brand Name : Faslodex

Dosage Form : Injection fluid, resolution

Dosage Strength : 250 mg/5 ml

Packaging : Finish filled syringe

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrantum

Brand Name : Faslodex

Dosage Form : Inj Solution

Dosage Strength : 250mg/5ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Fulvestrantum

Brand Name : Ambiful

Dosage Form : Inj L?s

Dosage Strength : 250mg/5ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

fulvestrant

Brand Name : Fulvestrant Sandoz

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 250 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank